The Delaware Court of Chancery has blocked Pfizer Inc. shareholders from access to board-level documents related to the pharmaceutical giant’s handling of some $69 billion in offshore earnings, ruling that the plaintiffs had failed to establish a credible basis for pursuing their books-and-records action.
